介入栓塞治疗肝血管瘤

目的 探讨介入栓塞治疗肝血管瘤的疗效。方法 收集18例经CDFI、MSCT、MRI及DSA确诊的肝血管瘤患者，采用Seldinger技术穿刺右股动脉，超选择至肿瘤供血动脉，以超液态碘油或平阳霉素超液态碘油乳剂，或联合明胶海绵颗粒和（或）明胶海绵条栓塞肿瘤血管。术后随访评价栓塞治疗疗效。结果 栓塞治疗术后患者临床症状均消失；血管瘤随时间延长而逐渐缩小，栓塞前血管瘤最大径为（10.20±3.24）cm，栓塞后血管瘤保持稳定时最大径为（4.44±2.16）cm，治疗前后差异有统计学意义（P<0.05）；介入栓塞治疗有效率为100%，无严重并发症发生。结论 介入栓塞治疗肝血管瘤创伤小、疗效可靠、并发症少，可作为肝血管瘤首选治疗方法。

Interventional embolotherapy in treatment of liver hemangioma

Objective To explore the therapeutic efficacy of interventional embolotherapy in treatment of hepatic hemangioma. Methods Totally 18 patients with hepatic hemangioma confirmed by CDFI, MSCT, MRI and DSA underwent interventional embolotherapy. Right arteria crurali was punctured using Seldinger technique, and embolization was performed with super-liquid lipiodol or pingyangmycin-super-liquid lipiodol emulsion as embolic materials, combining with gelfoam particles and/or gelfoam strip or not after super-selection of tumor feeding artery. These cases were followed-up after therapy, and the therapeutic efficacies were assessed. Results In all 18 patients, clinical symptoms relieved, the size of hemangiomas reduced with time after embolization. The preoperative maximum diameter of hemangioma was (10.20±3.24)cm, while postoperative maximum diameter of hemangioma was (4.44±2.16)cm when became stable (P<0.05). The effective rate of embolotherapy was 100%. No complications occurred. Conclusion Interventional embolotherapy is effective in treatment of hepatic hemangioma with fewer traumas and less complications, which can be used as the preferred treatment method for hepatic hemangioma.